TCPTP inactivation contributes to NASH and fibrosis via a STAT-1-dependent pathway, in contrast to HCC, which is promoted by a STAT-3-dependent pathway (Figure 2B) [116]. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatohepatitis.